Glen Eagle Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.7K | Hold |
260
| – | – | ﹤0.01% | 534 |
|
|
2025
Q1 | $17.8K | Hold |
260
| – | – | ﹤0.01% | 559 |
|
|
2024
Q4 | $20.2K | Sell |
260
-114
| -30% | -$8.87K | ﹤0.01% | 548 |
|
|
2024
Q3 | $25.1K | Hold |
374
| – | – | ﹤0.01% | 531 |
|
|
2024
Q2 | $42.4K | Buy |
374
+114
| +44% | +$12.9K | 0.01% | 430 |
|
|
2024
Q1 | $36.1K | Hold |
260
| – | – | 0.01% | 458 |
|
|
2023
Q4 | $32.3K | Hold |
260
| – | – | 0.01% | 456 |
|
|
2023
Q3 | $24.3K | Hold |
260
| – | – | 0.01% | 493 |
|
|
2023
Q2 | $33.4K | Hold |
260
| – | – | 0.01% | 437 |
|
|
2023
Q1 | $30.2K | Hold |
260
| – | – | 0.01% | 442 |
|
|
2022
Q4 | $29.4K | Hold |
260
| – | – | 0.01% | 433 |
|
|
2022
Q3 | $20.9K | Hold |
260
| – | – | 0.01% | 478 |
|
|
2022
Q2 | $19.4K | Hold |
260
| – | – | 0.01% | 505 |
|
|
2022
Q1 | $33.3K | Hold |
260
| – | – | 0.01% | 436 |
|
|
2021
Q4 | $34.9K | Hold |
260
| – | – | 0.01% | 428 |
|
|
2021
Q3 | $35.5K | Sell |
260
-200
| -43% | -$27.3K | 0.01% | 436 |
|
|
2021
Q2 | $49.1K | Hold |
460
| – | – | 0.02% | 375 |
|
|
2021
Q1 | $41.3K | Sell |
460
-120
| -21% | -$10.8K | 0.01% | 381 |
|
|
2020
Q4 | $53.6K | Buy |
580
+120
| +26% | +$11.1K | 0.02% | 317 |
|
|
2020
Q3 | $47.4K | Hold |
460
| – | – | 0.02% | 313 |
|
|
2020
Q2 | $46.6K | Buy |
+460
| New | +$46.6K | 0.02% | 296 |
|